Skeletal manifestations in a streptozotocin-induced C57BL/6 model of Type 1 diabetes

dc.contributor.authorHatch, Jennifer M.
dc.contributor.authorSegvich, Dyann M.
dc.contributor.authorKohler, Rachel
dc.contributor.authorWallace, Joseph M.
dc.contributor.departmentBiomedical Engineering, School of Engineering and Technology
dc.description.abstractDiabetes Mellitus is a metabolic disease which profoundly affects many organ systems in the body, including the skeleton. As is often the case with biology, there are inherent differences between the sexes when considering skeletal development and disease progression and outcome. Therefore, the aim of this study was to develop a protocol to reliably induce diabetes in both sexes of the C57BL/6 mouse utilizing streptozotocin (STZ) and to characterize the resulting bone phenotype. We hypothesized that destruction of the β-cells in the pancreatic islet by STZ would result in a diabetic state with downstream skeletal manifestations. Beginning at 8 weeks of age, mice were injected for 5 consecutive days with STZ (65 mg/kg males, 90 mg/kg females) dissolved in a citrate buffer. The diabetic state of the mice was monitored for 5 weeks to ensure persistent hyperglycemia and mice were euthanized at 15 weeks of age. Diabetes was confirmed through blood glucose monitoring, glucose and insulin tolerance testing, HbA1c measurement, and histological staining of the pancreas. The resulting bone phenotype was characterized using microcomputed tomography to assess bone structure, and whole bone mechanical testing to assess bone functional integrity. Mice from both sexes experienced loss of β-cell mass and increased glycation of hemoglobin, as well as reduced trabecular thickness and trabecular tissues mineral density (TMD), and reduced cortical thickness and cortical bone area fraction. In female mice the change area fraction was driven by a reduction in overall bone size while in male mice, the change was driven by increased marrow area. Males also experienced reduced cortical TMD. Mechanical bending tests of the tibiae showed significant results in females with a reduction in yield force and ultimate force driving lower work to yield and total work and a roughly 40 % reduction of stiffness. When tissue level parameters were estimated using beam theory, there was a significant reduction in yield and ultimate stresses as well as elastic modulus. The previously reported mechanistic similarity in the action of STZ on murine animals, as well as the ease of STZ administration via IP injection make this model is a strong candidate for future exploration of osteoporotic bone disease, Diabetes Mellitus, and the link between estrogen and glucose sensitivity.
dc.eprint.versionFinal published version
dc.identifier.citationHatch JM, Segvich DM, Kohler R, Wallace JM. Skeletal manifestations in a streptozotocin-induced C57BL/6 model of Type 1 diabetes. Bone Rep. 2022;17:101609. Published 2022 Aug 1. doi:10.1016/j.bonr.2022.101609
dc.relation.journalBone Reports
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.subjectDiabetes mellitus
dc.titleSkeletal manifestations in a streptozotocin-induced C57BL/6 model of Type 1 diabetes
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
575.7 KB
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
1.99 KB
Item-specific license agreed upon to submission